高危非致残性缺血性脑血管事件治疗进展

黄　环1; 2; 粟伟栋1; 2; 谭　红2

doi:10.12022/jnnr.2017-0075

PDF(774 KB)

神经病学与神经康复学杂志 ›› 2018, Vol. 14 ›› Issue (1) : 33-37. DOI: 10.12022/jnnr.2017-0075

综述

高危非致残性缺血性脑血管事件治疗进展

黄　环1,2，粟伟栋1,2，谭　红2

作者信息 +

Progress in treatment of high-risk non-disabling ischemic cerebrovascular events

HUANG Huan1, 2, SU Weidong1, 2, TAN Hong2

Author information +

文章历史 +

摘要

高危非致残性缺血性脑血管事件（high-risk non-disabling ischemic cerebrovascular event，HR-NICE）的早期精准治疗直接影响预后，故日益受到重视。尽管静脉溶栓是目前公认的缺血性卒中最有效的治疗手段，但对其在HR-NICE 患者中的疗效，尚存有争议。本文对近年来国内外HR-NICE 治疗的最新进展进行综述。

Abstract

The early and precise treatment of high-risk non-disabling ischemic cerebrovascular event (HR-NICE) has directly influenced on prognosis, and it attracts more attention. Although intravenous thrombolysis is generally acknowledged as the most effective therapy for ischemic stroke, but it is still in dispute for HR-NICE. This article reviews the domestic and abroad progress in HR-NICE in recent years.

导出引用

黄　环1,2，粟伟栋1,2，谭　红2. 高危非致残性缺血性脑血管事件治疗进展[J]. 神经病学与神经康复学杂志. 2018, 14(1): 33-37 https://doi.org/10.12022/jnnr.2017-0075

HUANG Huan1, 2, SU Weidong1, 2, TAN Hong2. Progress in treatment of high-risk non-disabling ischemic cerebrovascular events[J]. Journal of Neurology and Neurorehabilitation. 2018, 14(1): 33-37 https://doi.org/10.12022/jnnr.2017-0075